Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piero Berti

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
The Journal of Clinical Endocrinology and Metabolism|November 9, 2004
Identification of a novel point mutation in the RET gene (Ala883Thr), which is associated with medullary thyroid carcinoma phenotype only in homozygous conditionRossella Elisei, Barbara Cosci, Cristina Romei, et al.
Surgery|December 20, 2002
Preparation with iopanoic acid rapidly controls thyrotoxicosis in patients with amiodarone-induced thyrotoxicosis before thyroidectomyFausto Bogazzi, Paolo Miccoli, Piero Berti, et al.
Archives of Surgery (Chicago, Ill. : 1960)|December 22, 2010
Intensive risk-adjusted follow-up with the CEA, TPA, CA19.9, and CA72.4 tumor marker panel and abdominal ultrasonography to diagnose operable colorectal cancer recurrences: effect on survivalAndrea Nicolini, Paola Ferrari, Michael J Duffy, et al.
Clinical Endocrinology|September 13, 2008
Thiazolidinediones and antiblastics in primary human anaplastic thyroid cancer cellsAlessandro Antonelli, Silvia Martina Ferrari, Poupak Fallahi, et al.
Clinical Endocrinology|December 18, 2003
A reappraisal of the Rb1 gene abnormalities in the diagnosis of parathyroid cancerFilomena Cetani, Elena Pardi, Paolo Viacava, et al.
The Journal of Clinical Endocrinology and Metabolism|May 31, 2007
Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trialElena Ambrogini, Filomena Cetani, Luisella Cianferotti, et al.
European Journal of Endocrinology|May 1, 2007
Should parafibromin staining replace HRTP2 gene analysis as an additional tool for histologic diagnosis of parathyroid carcinoma?Filomena Cetani, Elena Ambrogini, Paolo Viacava, et al.
The Journal of Clinical Endocrinology and Metabolism|November 9, 2004
Genetic analyses of the HRPT2 gene in primary hyperparathyroidism: germline and somatic mutations in familial and sporadic parathyroid tumorsFilomena Cetani, Elena Pardi, Simona Borsari, et al.
Endocrine-Related Cancer|September 17, 2009
Dysregulation of secretion of CXC alpha-chemokine CXCL10 in papillary thyroid cancer: modulation by peroxisome proliferator-activated receptor-gamma agonistsAlessandro Antonelli, Silvia Martina Ferrari, Poupak Fallahi, et al.
Thyroid : Official Journal of the American Thyroid Association|October 16, 2003
Galectin-3 and oncofetal-fibronectin expression in thyroid neoplasia as assessed by reverse transcription-polymerase chain reaction and immunochemistry in cytologic and pathologic specimensRiccardo Giannini, Pinuccia Faviana, Tiziana Cavinato, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
The Journal of Clinical Endocrinology and Metabolism|November 9, 2004
Identification of a novel point mutation in the RET gene (Ala883Thr), which is associated with medullary thyroid carcinoma phenotype only in homozygous conditionRossella Elisei, Barbara Cosci, Cristina Romei, et al.
Surgery|December 20, 2002
Preparation with iopanoic acid rapidly controls thyrotoxicosis in patients with amiodarone-induced thyrotoxicosis before thyroidectomyFausto Bogazzi, Paolo Miccoli, Piero Berti, et al.
Archives of Surgery (Chicago, Ill. : 1960)|December 22, 2010
Intensive risk-adjusted follow-up with the CEA, TPA, CA19.9, and CA72.4 tumor marker panel and abdominal ultrasonography to diagnose operable colorectal cancer recurrences: effect on survivalAndrea Nicolini, Paola Ferrari, Michael J Duffy, et al.
Clinical Endocrinology|September 13, 2008
Thiazolidinediones and antiblastics in primary human anaplastic thyroid cancer cellsAlessandro Antonelli, Silvia Martina Ferrari, Poupak Fallahi, et al.
Clinical Endocrinology|December 18, 2003
A reappraisal of the Rb1 gene abnormalities in the diagnosis of parathyroid cancerFilomena Cetani, Elena Pardi, Paolo Viacava, et al.
The Journal of Clinical Endocrinology and Metabolism|May 31, 2007
Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trialElena Ambrogini, Filomena Cetani, Luisella Cianferotti, et al.
European Journal of Endocrinology|May 1, 2007
Should parafibromin staining replace HRTP2 gene analysis as an additional tool for histologic diagnosis of parathyroid carcinoma?Filomena Cetani, Elena Ambrogini, Paolo Viacava, et al.
The Journal of Clinical Endocrinology and Metabolism|November 9, 2004
Genetic analyses of the HRPT2 gene in primary hyperparathyroidism: germline and somatic mutations in familial and sporadic parathyroid tumorsFilomena Cetani, Elena Pardi, Simona Borsari, et al.
Endocrine-Related Cancer|September 17, 2009
Dysregulation of secretion of CXC alpha-chemokine CXCL10 in papillary thyroid cancer: modulation by peroxisome proliferator-activated receptor-gamma agonistsAlessandro Antonelli, Silvia Martina Ferrari, Poupak Fallahi, et al.
Thyroid : Official Journal of the American Thyroid Association|October 16, 2003
Galectin-3 and oncofetal-fibronectin expression in thyroid neoplasia as assessed by reverse transcription-polymerase chain reaction and immunochemistry in cytologic and pathologic specimensRiccardo Giannini, Pinuccia Faviana, Tiziana Cavinato, et al.
Pageof 6